Description

Lecirelin, also known as Dalmarelin or Reproreline, is a short-acting nonapeptide analogue of gonadotropin-releasing hormone (GnRH). It has demonstrated efficacy in inducing ovulation and resolving ovarian follicular cysts in veterinary species such as cattle, mares, and rabbits. Manufactured under GMP standards with a purity of ?99.61%, Lecirelin is an ideal reagent for reproductive physiology and veterinary endocrinology research. For laboratory research use only.

Product Specifications

Mechanism of Action & Research Applications

Lecirelin acts as a GnRH receptor agonist, triggering the release of luteinizing hormone (LH) and inducing ovulation. It’s used effectively in treating ovarian follicular cysts in cattle and in inducing ovulation in species like mares, rabbits, and camels . Research shows that, compared to other GnRH analogues, lecirelin can elicit a stronger LH surge, facilitating effective follicular development. For laboratory research use only.

Side Effects (For Reference Only in Models)

Experimental dosing of Lecirelin may lead to variable ovulation timing and hormonal fluctuations depending on dose and species. In certain cases, higher doses may correlate with increased abortion risk in lactating animals. These findings are for experimental planning only. For laboratory research use only.

Disclaimer

Lecirelin is provided strictly for laboratory research use only. It is not approved for human or veterinary clinical use. All handling must follow institutional safety and disposal protocols.